• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

Professional Introduction to Compound with CAS No. 75843-51-5 and Product Name: 2-(2-Isopropyl-5-methylphenoxy)acetohydrazide

The compound in question, identified by the CAS number 75843-51-5, is a specialized chemical entity that has garnered significant attention in the field of pharmaceutical research and development. The product name, 2-(2-Isopropyl-5-methylphenoxy)acetohydrazide, provides a detailed structural insight into its molecular composition, which includes a phenoxy group linked to an acetohydrazide moiety. This unique structural configuration suggests potential applications in medicinal chemistry, particularly in the synthesis of bioactive molecules.

Recent advancements in the field of drug discovery have highlighted the importance of structurally diverse compounds in addressing complex biological targets. The presence of the isopropyl and methyl substituents in the aromatic ring of 2-(2-Isopropyl-5-methylphenoxy)acetohydrazide may contribute to its pharmacological properties by influencing solubility, metabolic stability, and binding affinity to biological receptors. These features are critical in the design of novel therapeutic agents that aim to modulate physiological pathways effectively.

One of the most compelling aspects of this compound is its potential role as a precursor in the synthesis of more complex pharmacophores. The acetohydrazide group is a well-known pharmacological scaffold that has been utilized in various drug molecules due to its ability to form hydrogen bonds and interact with biological targets. Researchers have been exploring derivatives of acetohydrazides for their antimicrobial, anti-inflammatory, and anticancer properties. The specific substitution pattern in 2-(2-Isopropyl-5-methylphenoxy)acetohydrazide may enhance its efficacy in these applications by optimizing its interaction with target enzymes and receptors.

Current research trends indicate that compounds with phenoxy groups are of particular interest due to their versatility in drug design. The phenoxy moiety can serve as a hinge region, allowing for the modulation of molecular interactions through conformational changes. This flexibility makes it an attractive component in the development of small-molecule inhibitors and agonists. Moreover, the isopropyl and methyl groups contribute to steric hindrance, which can be strategically employed to improve binding affinity and reduce off-target effects.

In vitro studies have begun to uncover the mechanistic potential of 2-(2-Isopropyl-5-methylphenoxy)acetohydrazide. Initial experiments suggest that it may exhibit inhibitory activity against certain enzymes implicated in inflammatory responses. The compound's ability to interfere with key signaling pathways could make it a valuable tool for developing novel therapeutics targeting chronic inflammatory diseases. Additionally, its structural features may allow it to cross biological membranes efficiently, enhancing its bioavailability and therapeutic index.

The synthesis of 2-(2-Isopropyl-5-methylphenoxy)acetohydrazide involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to construct the desired molecular framework efficiently. These synthetic strategies not only highlight the compound's complexity but also demonstrate the sophistication of modern pharmaceutical chemistry.

As computational chemistry plays an increasingly pivotal role in drug discovery, virtual screening techniques have been applied to evaluate the potential binding interactions of 2-(2-Isopropyl-5-methylphenoxy)acetohydrazide with biological targets. Molecular docking studies have revealed promising binding affinities with enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are central players in inflammatory processes. These computational findings provide a strong rationale for further exploring the pharmacological properties of this compound.

The future prospects for 2-(2-Isopropyl-5-methylphenoxy)acetohydrazide are promising, with ongoing research aimed at optimizing its chemical structure for improved efficacy and safety profiles. Collaborative efforts between academic institutions and pharmaceutical companies are likely to drive innovation in this area, leveraging interdisciplinary approaches such as structure-based drug design and high-throughput screening technologies. The compound's unique structural features make it a compelling candidate for further investigation in preclinical models.

In conclusion, 75843-51-5 represents a fascinating chemical entity with significant potential in pharmaceutical applications. The product name 2-(2-Isopropyl-5-methylphenoxy)acetohydrazide underscores its complex molecular architecture, which may translate into diverse biological activities. With continued research and development, this compound could emerge as a valuable asset in the quest for novel therapeutic interventions across various disease indications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)